Skip to content

A randomized controlled clinical study of computer deep learning assisted anesthesia for TURBT

A randomized controlled clinical study of computer deep learning assisted anesthesia for TURBT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036144
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early bladder tumor

Interventions

AI Group:AI assisted
non-AI Group :non AI assisted

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. The patient was diagnosed with superficial bladder tumor and TURBT surgery was performed under general anesthesia at a selected stage; 3. ASA grade I or II; 4. BMI, 18 kg/m2 or and 30 kg/m2 or less; 5. Operation time <= 2 hours; 6. Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Previous severe cerebrovascular accidents and other neurological disease; 2. Mental illness, long-term use of drugs that affect the function of the central nervous system, benzodiazepines or opioids; 3. History of allergy to anesthetic drugs; 4. History of drug addiction and alcohol abuse; 5. The patient was diagnosed as having uncontrolled severe hypertension, severe cardiopulmonary diseases, or severe liver and kidney diseases; 6.Participate in other clinical trials within 4 weeks; 7. Cognitive or communication abnormalities determined by the investigator; 8. Emergency and critical condition occurred during the operation; 9. Patients with neuromuscular connector disease; 10.TURBT contraindications, including obvious abnormality of coagulation function, invasive bladder tumor of muscular layer, acute cystitis, deformity of the spine, unsupine, urethral stricture, etc.; 11. Patients under general anesthesia are not recommended.

Design outcomes

Primary

MeasureTime frame
Residual incidence of postoperative muscle relaxants;

Countries

China

Contacts

Public ContactPeiying Li

Renji Hospital, School of Medicine, Shanghai Jiaotong University

peiying.li@qq.com+86 15800616866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026